Martin B. Finkelstein
-
- Bone health and treatments 2
- Biochemistry top 10%
-
- Prostate Cancer Treatment and Research 3
- Advanced Breast Cancer Therapies 2
-
- Click Chemistry and Applications 2
- Ferrocene Chemistry and Applications 2
- Synthesis and Characterization of Heterocyclic Compounds 1
-
- Hormonal and reproductive studies 2
-
- Neuroendocrine Tumor Research Advances 1
- Co-authors
- Nasir KhanWenyue HuStéphane ThibaultTae SungBart JessenAida SacaanM. W. AndersRaymond B. Baggs
- Journals
- Chemical Research in Toxicology (3 papers)Clinical Cancer Research (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesChileUnited Kingdom
In The Last Decade
Martin B. Finkelstein
14 papers receiving 378 citations
Peers
Comparison fields: 5 of 56
- Oncology 207
- Biochemistry 50
- Pulmonary and Respiratory Medicine 151
- Developmental Neuroscience 17
- Genetics 37
Countries citing papers authored by Martin B. Finkelstein
This map shows the geographic impact of Martin B. Finkelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin B. Finkelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin B. Finkelstein more than expected).
Fields of papers citing papers by Martin B. Finkelstein
This network shows the impact of papers produced by Martin B. Finkelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin B. Finkelstein. The network helps show where Martin B. Finkelstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin B. Finkelstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 0 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 5 | |
| 5 | 2019 | 31 | |
| 6 | 2019 | 91 | |
| 7 | 2019 | 0 | |
| 8 | 2018 | 23 | |
| 9 | 2015 | 132 | |
| 10 | 2008 | 9 | |
| 11 | 1996 | 18 | |
| 12 | 1996 | 7 | |
| 13 | 1995 | 11 | |
| 14 | 1995 | 10 | |
| 15 | 1994 | 14 | |
| 16 | 1992 | 29 |
About Martin B. Finkelstein
Martin B. Finkelstein is a scholar working on Oncology, Pharmaceutical Science, Pulmonary and Respiratory Medicine, Rehabilitation and Nephrology, having authored 16 papers that have together received 383 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Advanced Breast Cancer Therapies (2 papers), Bone health and treatments (2 papers), Click Chemistry and Applications (2 papers), Ferrocene Chemistry and Applications (2 papers), Hormonal and reproductive studies (2 papers), Synthesis and Characterization of Heterocyclic Compounds (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (207 citations), Biochemistry (50 citations), Pulmonary and Respiratory Medicine (151 citations), Developmental Neuroscience (17 citations) and Genetics (37 citations). Martin B. Finkelstein has collaborated with scholars based in United States, Chile and United Kingdom. Frequent co-authors include Nasir Khan, Wenyue Hu, Stéphane Thibault, Tae Sung, Bart Jessen, Aida Sacaan, M. W. Anders, Raymond B. Baggs, Changhua Ji and Allison Vitsky. Their work appears in journals such as Chemical Research in Toxicology, Clinical Cancer Research, Journal of Pharmacology and Experimental Therapeutics, Toxicologic Pathology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.